Moleculent
PrivateLast Round
Series A
Extension
Apr 30, 2026
Total Funding Raised
$46M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Moleculent is a biotechnology company that develops a functional profiling platform to map cell-cell communication directly within clinical tissue.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Moleculent Comparables
Compare Moleculent with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pixelgen Technologies | 86% | |
| Takara Bio Inc. | 84% | |
| Stellaromics | 82% |
Moleculent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 30, 2026 | ||||
| Series A | Jun 11, 2024 |
Key People
Founding team and executive leadership
Moleculent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rubicon Healthcare Partners | Series A Extension |
| ARCH Venture Partners | Series A Extension, Series A |
| Eir Ventures | Series A Extension, Series A |
| ARCH Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 1292% MoM, reaching 5.2K.
- Apr 30, 2026
$20M raised with Rubicon Healthcare Partners leading.
Moleculent Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Moleculent's valuation, stock price, and market status.
Is Moleculent a public or private company?
Moleculent is a private company.
What is the current stock price of Moleculent?
Moleculent is a private company with no public stock price. No recent secondary market data is available.
How much is Moleculent worth (valuation)?
Valuation information for Moleculent is not publicly available.
Can I buy Moleculent stock?
Moleculent shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Moleculent's last funding round?
Moleculent's most recent funding round was Series A Extension on April 30, 2026.
Who are the main investors in Moleculent?
Key investors in Moleculent include Rubicon Healthcare Partners, Eir Ventures, ARCH Venture Partners.
Will Moleculent IPO soon?
No public IPO plans have been announced for Moleculent.
How can I track Moleculent secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Moleculent's secondary market activity and sign up for updates.